DF/HCC has received from NCI three separate P30 supplement opportunities in AIDS-related malignancies. They will conduct an internal review at DF/HCC to select projects for each opportunity. If you have a project you would like considered for one of these applications, please submit the following information by e-mail to Jun-Rong Wei, no later than 2/26/24: A. Name,…Continue Reading DF/HCC Funding Opportunity for HIV/AIDS-related Malignancies